What should I know first?

Major depression involves a sustained period of low mood or loss of interest, together with other symptoms that disrupt life. It is more than an ordinary difficult day. People may look outwardly capable while finding basic routines exhausting.

Signs and Symptoms

Symptoms can include sadness or irritability, reduced enjoyment, changes in sleep or appetite, low energy, difficulty thinking and feelings of worthlessness. Some people experience thoughts of death or suicide. Not everyone has the same combination, and children may seem irritable rather than sad.

How Is It Diagnosed?

NICE recommends assessment beyond a symptom count: duration, previous episodes, functioning, physical health and social circumstances all matter. A clinician should ask about previous periods of unusually elevated mood that might indicate bipolar disorder.

The DSM description uses a sustained symptom pattern over at least two weeks. Assessment explores the symptoms, their effect on life and past episodes. Assessment also considers medicines, physical illness and any history of mania or hypomania. A screening score alone cannot establish major depressive disorder.

How Common Is It?

In the 2021 US National Survey on Drug Use and Health, 8.3% of adults aged 18 or older reported a major depressive episode during the previous year. That survey definition did not exclude episodes associated with medical illness, substances or medicines, so it is not identical to a clinical diagnosis of major depressive disorder. These are not UK population estimates.

Causes and Risk Factors

Depression reflects interacting genetic, biological, psychological and environmental factors. Loss, illness or adversity can contribute, but there is not always an obvious trigger. An explanation based on weakness or a single chemical deficit does not capture this complexity.

What Do We Know About the Brain?

Researchers study brain functioning and how people respond to different treatments. These studies aim to improve care; they do not show that every person with depression has the same biological cause or will benefit from the same treatment.

What Else Can Look Similar?

Bipolar depression, thyroid problems, medicine effects and other illnesses can produce similar difficulties. Grief and persistent depressive disorder also need consideration. A history of unusually elevated energy, reduced need for sleep or marked mood changes is important to share during assessment.

Conditions That Can Occur Together

Depression may occur with anxiety, substance use problems, chronic pain or other physical illnesses. Supporting one condition can be harder when another is overlooked. An assessment should consider the whole situation, including sleep and everyday functioning.

Treatment and Support

Options include guided self-help, psychological therapy and medicines. NICE distinguishes less severe from more severe depression and recommends shared treatment decisions. In England, eligible adults can self-refer to NHS Talking Therapies; other nations have their own pathways.

NICE implementation and access differ across the four UK nations.

Talking therapies include cognitive behavioural therapy, interpersonal therapy and behavioural activation. Treatment is chosen with the person, considering severity, preferences and previous response. Severe or persistent depression may need specialist care; brain stimulation can be considered in selected situations.

The adult pathway should not be applied unchanged to children. NICE NG134 separately addresses childhood and adolescent depression, with developmentally appropriate psychological care and specialist decisions about medicines. Families should be involved in ways appropriate to the young person’s needs and circumstances.

Children and young people need the separate NICE NG134 pathway. Mild depression is usually managed with support and age-appropriate psychological treatment; antidepressants are not the initial treatment. Moderate or severe depression needs specialist assessment. Therapy choices differ between ages 5–11 and 12–18 and should consider development, preferences, family circumstances and risk.

Can Medication Help?

NICE does not routinely recommend antidepressants first for less severe depression unless the person makes an informed choice for them. More severe depression may benefit from psychological treatment combined with an antidepressant.

Antidepressants help some people, sometimes alongside talking therapy. Improvement and unwanted effects need follow-up. Seek prompt help for newly worsening suicidal thoughts, and discuss changes with the prescriber instead of stopping suddenly. A medicine's approval, age limits and warnings are product-specific.

The recommendations above concern adults. For children and young people with moderate or severe depression, fluoxetine may be considered alongside psychological therapy through specialist care. Its UK depression licence starts at eight after inadequate response to 4–6 therapy sessions; younger use is off-label. Treatment under 12 needs particular caution because evidence is more limited.

Agree close early contact, commonly weekly during the first four weeks, and a plan for new suicidal thoughts, self-harm, hostility or other concerning changes. A child and adolescent psychiatrist should assess the need for an antidepressant. Medicine is not automatically appropriate for every child with depression.

What to Expect Over Time

Many people improve with treatment, while others need a different approach or longer support. Episodes can recur. Continuing agreed care and discussing early signs of relapse can be part of the plan; recurrence is a reason to seek support, not a personal failure.

Everyday Life and Support

Small, manageable activities and contact with supportive people can help during recovery. Practical assistance with appointments, meals or daily tasks may be more useful than pressure to feel positive. Ask the healthcare team what to do if symptoms worsen.

When to Seek Urgent Help

Suicidal intent, serious self-neglect or inability to remain safe requires urgent help. Contact local emergency services when danger is immediate.

History

NICE’s 2022 adult guideline uses less severe and more severe depression to organise treatment choices. These guidance categories should not be mistaken for a new diagnostic test.

Diagnostic descriptions of depression have been revised to make assessment more consistent while retaining the need for clinical judgement. A federal comparison of DSM-IV and DSM-5 records that both descriptions required a sustained cluster of symptoms and meaningful distress or difficulty functioning.

DSM-5 placed major depression in a separate depressive-disorders group instead of the broader mood-disorders grouping. It also removed the earlier bereavement exclusion. That change does not mean ordinary grief automatically becomes a disorder: the person's experience, culture, functioning and full symptom pattern still matter.

The historical distinction between depression without mania and depression within bipolar disorder remains especially important, because similar low periods can occur in conditions with different treatment needs.

Sources and References

  1. Depression in adults: overview
  2. Depression in adults: treatment and management — recommendations
  3. About this quality standard: national applicability
  4. Find NHS talking therapies for anxiety and depression
  5. Depression
  6. DSM-IV to DSM-5 Major Depressive Episode/Disorder Comparison
  7. Major Depression: 2021 survey estimates
  8. Depression research and health information
  9. Depression in adults: treatment
  10. Depression in children and young people — recommendations

    Scope: United Kingdom; NICE recommendations require attention to national implementation and local pathways.

  11. Fluoxetine 20 mg capsules — UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom; NICE recommendations require attention to national implementation and local pathways.

  12. ICD-10, fifth edition: Mood [affective] disorders (F30–F39)

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top